UMU logo


The KBC-based Magnetic Resonance Platform at Umeå University offers access to NMR spectrometers at 100-600 MHz, with instruments for solution NMR at 600 (with cryoprobes), 500, 400 and 360 MHz, widebore systems for solid state NMR (100 and 400 MHz) and microimaging (400 MHz), and equipment (HR-MAS) for semi-solid samples at 500 MHz.

We offer access to the following NMR spectrometers:

Solution NMR:

600 MHz (with cryoprobes)
500 MHz
400 MHz
360 MHz

Solid state NMR:
500 MHz narrowbore HR-MAS
400 MHz widebore
100 MHz widebore
Imaging and pfg-NMR:
400 MHz microimaging
400 MHz diffusion

Based on major funding by Wallenberg and Kempe, the NMR machines provide a unique platform, where all the different NMR techniques (solution, solid, diffusion, imaging) can be used simultaneously in a highly synergetic way. The platform provides service and access to all KBC and Campus groups, as well as training in state-of-the-art NMR methodology. In addition it has an open-access policy for academic/industrial partners at a national/international level.

Connected with this facility is an internationally well recognized, highly collaborative NMR community at UmU (ca. 15 groups) who cover a wide scope of basic and applied research including:

materials- and environmental sciences
NMR methods development
post-genomic derived systems in plants (green factory)
biological processes in human health and disease

Examples are:
membrane lipids and their proteins
amyloidogenic and allergenic proteins
proteins suitable for dynamics and folding studies
bioactive RNA/DNA complexes; often areas of major medical and pharmaceutical interest.

The platform acts even as core facility for several major research projects (Berzelius Center, Umeå Center for Microbial Research, Wallenberg: Molecules for the Future) and two Graduate Research Schools.
To maintain this platform at a high international level in the future and make it available for a wider range or interested goups (nationally and internationally), the current platform development is targeted towards the removal of the current critical shortage of NMR time at high-field, the missing of an in-house, permanently accessible high-field (800-900 MHz) machine.

For booking and information, please contact:
play Tobias Sparrman

Emmanuelle Charpentier:
MIMS is characterized by
ECharpentier about MIMS 2015 1

Emmanuelle Charpentier, Alumna at MIMS, now Director of the Max Planck Unit for the Science of Pathogens and Director of the Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Berlin, Germany.

Link to the Emmanuelle Charpentier Lab

footer all slides 2014-02-06

Copyright © 2017 by The Laboratory for Molecular Infection Medicine Sweden (MIMS). All rights reserved.